Literature DB >> 24881724

What is the best animal model for acs?

A Schachtrupp, J Wauters, A Wilmer.   

Abstract

INTRODUCTION: Current treatment of the abdominal compartment syndrome (ACS) is based on consensus definitions but several questions regarding fluid regime or critical level of intra-abdominal hypertension (IAH)) remain unsolved. It is questionable whether these issues can be addressed in prospective randomized trials in the near future. This review aimed to summarize current animal models and to outline requirements for the best model.
METHODS: PubMed® data base was searched for articles describing animal models of ACS.
RESULTS: 25 articles were found. ACS in animals has not been defined yet. Investigations varied considerably regarding the experimental design. Animals were rats, rabbits, dogs and pigs with a bodyweight from 200g to 70 kg. IAP increase varied from 20 to 50 mmHg. The time period of IAH ranged between 30 min and 24h. The time between the IAH insult and organ dysfunction varied between 15 min and 18h. Investigations demonstrated that IAH is able to induce loss of intravascular volume, organ hypoperfusion, ischemic organ damage and multiple organ failure within 4 to 6h.
CONCLUSION: In contrast to IAH or pneumoperitoneum for surgical exposure, ACS in an animal may be stated if an artificially increased IAP leads to circulatory, respiratory and renal insufficiency. A next step in animal research would be the development of a "pathological" model in which haemorrhage or systemic inflammation together with resuscitation lead to abdominal fluid accumulation and increased intra-abdominal pressure.

Entities:  

Keywords:  Abdominal compartment syndrome,; animal model; experimental,; intra-abdominal hypertension,; intra-abdominal pressure,

Year:  2007        PMID: 24881724     DOI: 10.1179/acb.2007.62.s1.031

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  4 in total

1.  Bench Validation of a Handcrafted Prototype Catheter for Intra-gastric Pressure Monitoring.

Authors:  Alberto Federico García; Julián Chica Yantén; Álvaro Ignacio Sánchez; Jose Luis Aldana; Jorge Humberto Mejía; Daniela Burbano; Camilo Salazar
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

2.  Pressure Distribution during Negative Pressure Wound Therapy of Experimental Abdominal Compartment Syndrome in a Porcine Model.

Authors:  Adrienn Csiszkó; Klaudia Balog; Zoltán Attila Godó; Gyula Juhász; Katalin Pető; Ádám Deák; Mariann Berhés; Norbert Németh; Zsolt Bodnár; Zsolt Szentkereszty
Journal:  Sensors (Basel)       Date:  2018-03-17       Impact factor: 3.576

3.  An Ingestible Electronics for Continuous and Real-Time Intraabdominal Pressure Monitoring.

Authors:  Chien-Hung Liao; Chi-Tung Cheng; Chih-Chi Chen; Uei-Ming Jow; Chun-Hung Chen; Yen-Liang Lai; Ya-Chuan Chen; Dong-Ru Ho
Journal:  J Pers Med       Date:  2020-12-24

4.  Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats.

Authors:  Marijan Tepes; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Hrvoje Vranes; Zrinko Madzar; Goran Santak; Lovorka Batelja; Marija Milavic; Suncana Sikiric; Ivica Kocman; Karol Simonji; Mariam Samara; Mario Knezevic; Ivan Barisic; Eva Lovric; Sanja Strbe; Antonio Kokot; Ivica Sjekavica; Toni Kolak; Anita Skrtic; Sven Seiwerth; Alenka Boban Blagaic; Predrag Sikiric
Journal:  Front Pharmacol       Date:  2021-12-13       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.